Physician profile
Stacy E Ong
NPI 1356345821
$4,409.58
in general payments reported to CMS, 2019-2025
41 companies · $755 in 2025
The $755 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $601 · 2020: $374 · 2021: $558 · 2022: $454 · 2023: $701 · 2024: $967 · 2025: $755.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,378 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,378.18 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $511.20 | 2020-2024 | Axonics |
| Coloplast Corp | $439.89 | 2019-2025 | Porges Coloplast, Speedicath |
| Allergan, INC. | $354.42 | 2019-2022 | |
| Boston Scientific Corporation | $321.23 | 2019-2022 | |
| Abbvie INC. | $318.59 | 2022-2025 | |
| Progenics Pharmaceuticals, INC. | $241.24 | 2023-2025 | Pylarify |
| Astellas Pharma US INC | $227.89 | 2019-2025 | Veozah, Myrbetriq |
| 180 Medical, INC. | $214.39 | 2021-2025 | |
| Clarus Therapeutics INC. | $168.95 | 2020-2021 | |
| Antares Pharma, INC. | $162.51 | 2020-2025 | Xyosted, Tlando, Nocdurna |
| Novo Nordisk INC | $150.15 | 2024-2025 | Ozempic, Rivfloza |
| Janssen Biotech, INC. | $122.42 | 2022-2024 | Erleada, Akeega |
| Millicent US INC | $117.58 | 2020-2025 | Intrarosa |
| Olympus America INC. | $108.06 | 2023-2025 | Itind System, Soltive, Uretero-Reno Videoscope |
| Bluewind Medical | $88.90 | 2024 | Revi |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacy Ong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.